Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Sep-30-04 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Surgical Facilities | 128.5 | 131.2 | 116.4 | 105.8 | 81.1 | 57.3 | 45.7 | |
| Product Sales | 15.5 | 14.7 | 16.4 | 15.3 | 15.4 | 13.5 | 10.6 | |
| Other | 7.8 | 8.1 | 7.3 | 7.5 | 7.7 | 7.5 | 7.3 | |
| Corporate | | | | 0.0 | 0.1 | 0.1 | | |
| Total revenues | 151.8 | 154.0 | 140.2 | 128.6 | 104.3 | 78.4 | 63.6 | 0.0 |
| Revenue growth [+] | -1.4% | 9.9% | 9.0% | 23.4% | 33.0% | 23.2% | | |
| Surgical Facilities | -2.0% | 12.7% | 10.1% | 30.4% | 41.4% | 25.5% | | |
| Product Sales | 5.1% | -10.0% | 6.8% | -0.5% | 14.3% | 26.7% | | |
| Other | -3.7% | 10.3% | -2.2% | -2.4% | 2.2% | 3.0% | | |
| Corporate | | | | -56.7% | 11.1% | | | |
| Cost of goods sold | 45.0 | 45.6 | 42.0 | 39.8 | 34.2 | 25.1 | 21.4 | 0.0 |
| Gross profit | 106.8 | 108.5 | 98.1 | 88.8 | 70.1 | 53.3 | 42.2 | 0.0 |
| Gross margin | 70.4% | 70.4% | 70.0% | 69.0% | 67.2% | 68.0% | 66.3% | |
| Selling, general and administrative | 28.1 | 27.4 | 25.5 | 23.5 | 18.9 | 15.7 | 13.5 | |
| Other operating expenses | 41.9 | 41.0 | 36.8 | 30.2 | 25.4 | 19.1 | 15.4 | |
| EBITDA [+] | 42.0 | 45.9 | 40.1 | 35.5 | 26.1 | 18.7 | 13.3 | |
| EBITDA growth | -8.4% | 14.4% | 13.0% | 36.0% | 39.9% | 40.1% | | |
| EBITDA margin | 27.7% | 29.8% | 28.6% | 27.6% | 25.1% | 23.8% | 20.9% | |
| Depreciation and amortization | 5.2 | 5.9 | 4.3 | 4.0 | 3.1 | 2.5 | 2.4 | |
| EBIT [+] | 36.9 | 40.0 | 35.8 | 31.5 | 23.0 | 16.2 | 10.9 | 0.0 |
| EBIT growth | -7.9% | 11.7% | 13.7% | 36.8% | 42.2% | 48.8% | | |
| EBIT margin | 24.3% | 26.0% | 25.6% | 24.5% | 22.1% | 20.7% | 17.1% | |
| Interest expense, net [+] | 8.9 | 8.8 | 8.1 | 6.6 | 2.9 | 0.7 | 0.1 | |
| Interest expense | 8.9 | 8.8 | 8.1 | 6.8 | 3.0 | 0.8 | 0.2 | |
| Interest income | 0.0 | 0.0 | 0.1 | 0.2 | 0.1 | 0.0 | 0.1 | |
| Other income (expense), net | 0.3 | 0.0 | 0.0 | -0.9 | -11.0 | -6.7 | -6.2 | 2.5 |
| Pre-tax income | 28.3 | 31.2 | 27.7 | 24.0 | 9.1 | 8.8 | 4.5 | 2.5 |
| Income taxes | 4.4 | 5.3 | 4.4 | 3.9 | 3.5 | 3.5 | 2.4 | 1.6 |
| Tax rate | 15.6% | 16.9% | 16.0% | 16.3% | 39.0% | 40.0% | 54.3% | 64.7% |
| Minority interest | 16.7 | 17.7 | 16.4 | 15.3 | 11.4 | 7.3 | 4.9 | |
| Earnings from continuing ops | -11.3 | -10.2 | -9.2 | -10.8 | 5.5 | 5.3 | 2.1 | 0.9 |
| Earnings from discontinued ops | 22.0 | 25.2 | 23.6 | -2.7 | 5.7 | 5.6 | 0.8 | 0.0 |
| Net income | 10.6 | 15.0 | 14.4 | -13.4 | 11.3 | 10.8 | 2.8 | 0.9 |
| Net margin | 7.0% | 9.8% | 10.3% | -10.5% | 10.8% | 13.8% | 4.5% | |
| |
| Basic EPS [+] | ($0.74) | ($0.67) | ($0.57) | ($0.22) | $0.12 | $0.12 | $0.09 | $42,750.00 |
| Growth | 9.4% | 17.8% | 155.0% | -282.5% | 1.4% | 29.2% | | |
| Diluted EPS [+] | ($0.73) | ($0.65) | ($0.55) | ($0.22) | $0.11 | $0.11 | $0.09 | $42,750.00 |
| Growth | 11.2% | 19.5% | 152.7% | -291.2% | 1.4% | 28.7% | | |
| |
| Shares outstanding (basic) [+] | 15.4 | 15.2 | 16.0 | 48.0 | 45.1 | 43.4 | 21.9 | 0.0 |
| Growth | 1.6% | -5.4% | -66.6% | 6.5% | 4.0% | 98.1% | | |
| Shares outstanding (diluted) [+] | 15.6 | 15.6 | 16.8 | 49.8 | 49.0 | 47.1 | 23.7 | 0.0 |
| Growth | 0.0% | -6.8% | -66.3% | 1.6% | 4.0% | 98.7% | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|